Pfizer CEO Albert Bourla said on Sunday his company would start making efforts to make children eligible for the company’s COVID-19 vaccine “very soon.”
“I think we’ll be submitting this data very soon. It’s a matter of days, not weeks,” Bourla told ABC’s “This Week”.
“It’s a matter of days, not weeks.” https://t.co/Ekqp2WJEV7 pic.twitter.com/4F6QoLgL34
– This week (@ThisWeekABC) September 26, 2021
Bourla noted that the Food and Drug Administration (FDA) would review the data after it is submitted and make official decisions about approval.
Bourla said Pfizer would be ready to make more doses for children if needed. He added that children between the ages of 5 and 11 would receive about a third of the dose adults receive.
Pfizer announced on September 20 that research has shown its vaccine to be safe and effective for children aged 5 to 11.
“In the past nine months, hundreds of millions of people aged 12 and over around the world have received our COVID-19 vaccine,” Bourla said at the time of the announcement. “We look forward to extending the protection offered by the vaccine to this younger population, subject to regulatory approval, especially as we follow the spread of the Delta variant and the substantial threat it poses to them. children. ”